In rat microglia cells, combined LPS and Sinomenine treatment yielded 20 differentially expressed miRNAs compared with LPS alone, including 11 upregulated and 9 downregulated miRNAs. In BV2 cells, Sinomenine pretreatment did not affect the ADDL-induced increase in IL-12 compared with ADDL alone. In B16-F10 cells, Sinomenine decreased viability in a dose-dependent manner. [1,2,3]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Sinomenine and LPS treatment in rat microglia
Cell-based study · Rat microglia (RM) cells [1]
Rat microglia cells treated with both LPS and Sinomenine were compared with cells treated with LPS alone. Sequencing identified 20 differentially expressed miRNAs, with 11 upregulated and 9 downregulated.
Literature-Reported Treatment Conditions
- Treatment concentration
- 0.5 µM
- Exposure duration
- 1 µg/mL LPS for 4 h; with or without SINO for 24 h
- Method
- Subsequently, the cells were treated with or without SINO
- Co-treatment
- Other interventions in this design: LPS 1 µg/mL. Compound effect isolated by the comparison: RM cells treated with LPS alone (LPS-RM-Exos); RM cells treated with both LPS and SINO (SINO-RM-Exos).
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Sinomenine
The paper names Sinomenine without stating the salt or form; not verified as the hydrochloride form supplied as A12221. No dose conversion or lot validation.
Materials and methods > Microglial cell culture and treatments (S48); Materials and methods > Isolation and identification of RM exosomes (RM-Exos) (S77, S78); Materials and methods > miRNA microarray analysis (S90); Results > SINO suppresses the LPS-induced inflammatory response in RM cells and enhances their M2 polarization (S163); Results > Exosomal mir-223-3p mediates the protective effects of SINO-activated microglia on neuronal pyroptosis (S192, S193, S197); Fig. 1 legend (S209)
miRNA sequencing analysis: miRNA sequencing analysis; comparator: RM cells treated with LPS alone (LPS-RM-Exos) — Results > SINO suppresses the LPS-induced inflammatory response in RM cells and enhances their M2 polarization (S163); Results > Exosomal mir-223-3p mediates the protective effects of SINO-activated microglia on neuronal pyroptosis (S192, S193, S197)
Sinomenine pretreatment in ADDL-exposed microglial cells
Cell-based study · BV2 cells [2]
BV2 cells received Sinomenine before ADDL exposure. Compared with ADDL alone, Sinomenine pretreatment did not affect the ADDL-induced increase in IL-12.
Literature-Reported Treatment Conditions
- Treatment concentration
- 10-4 M
- Exposure duration
- sinomenine for 1.5 h, then with ADDL for 12 h
- Method
- treated with sinomenine before addition of ADDL
- Vehicle
- DMSO concentration was 0.1%
- Co-treatment
- Other interventions in this design: ADDL 2 μM. Compound effect isolated by the comparison: compared to ADDL.
- Reported limits
- Removed after verification: value.
Methods and source locations
Compound reported in the paper: Sinomenine
The paper names Sinomenine without stating the salt or form; not verified as the hydrochloride form supplied as A12221. No dose conversion or lot validation.
Methods > Preparation of oligomeric amyloid beta (S8); Methods > Cell culture and treatments (S9, S15); Methods > Cytokine bead array assay (S47); Results > Sinomenine inhibits amyloid-β-induced increase in level of reactive oxygen species in microglial cells (S67, S71, S72, S73, S77); Results > Sinomenine reduces A-beta-induced increases in inflammatory molecules (S89, S95)
levels of IL-6, IL-10, IL-12, TNF-α, IFN-γ and MCP-1: levels of IL-6, IL-10, IL-12, TNF-α, IFN-γ and MCP-1; comparator: ADDL — Methods > Cell culture and treatments (S15); Results > Sinomenine inhibits amyloid-β-induced increase in level of reactive oxygen species in microglial cells (S67, S71, S72); Results > Sinomenine reduces A-beta-induced increases in inflammatory molecules (S89, S95)
Sinomenine effects on melanoma cell viability
Cell-based study · B16-F10 cells [3]
B16-F10 cells were treated with Sinomenine, and viability was assessed using a CCK8 assay. Sinomenine decreased cell viability in a dose-dependent manner.
Literature-Reported Treatment Conditions
- Treatment concentration
- 0, 12.5, 25, 50, and 100 μM
- Exposure duration
- 24 hours
- Reported limits
- Not stated in the sentences used: route, vehicle.
Methods and source locations
Compound reported in the paper: Sinomenine
The paper names Sinomenine without stating the salt or form; not verified as the hydrochloride form supplied as A12221. No dose conversion or lot validation.
Materials and methods > Cell viability assay (S11); Results > SIN inhibits proliferation and promotes apoptosis of B16-F10 cells (S40, S41); Figure 1 legend (S60, S61, S67)
cell viability was analyzed by CCK8 assay: cell viability was analyzed by CCK8 assay; comparator: untreated control — Results > SIN inhibits proliferation and promotes apoptosis of B16-F10 cells (S40, S41); Figure 1 legend (S61)